Skip to main content

Genvec Value Stock - Dividend - Research Selection


ISIN: US37246C4069, WKN: A2DHJW

Market price date: 30.11.-0001
Market price: 0,00 USD

Genvec Fundamental data and company key figures of the share

Annual reports in USD
Key figures 06-03-2017
Cash flow
Net operating cash flow -5.983.000
Capital Expenditures -19.000
Free cash flow -6.002.000
Balance sheet
Total Equity 4.705.000
Liabilities & Shareholders equity 7.707.000
Income statement
Net income -5.787.000
Eps (diluted) -2,780
Diluted shares outstanding 2.000.000
Net sales/revenue 511.000

Fundamental ratios calculated on: 30-11--0001

Key figures 30-11--0001
Cash flow
P/C 0,00
P/FC 0,00
Balance sheet
Income statement
Div. Yield0,00%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization14.380.000,00 USD
Raw Data Source
Stock Split

Description of the company

GenVec, Inc. develops gene-based pharmaceuticals and therapies for the treatment of major medical needs. The Company combines its patented gene transfer technologies with proprietary therapeutic genes to create product candidates that address needs in the areas of cardiovascular disease, cancer and other therapeutic areas.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,